Francisco David (CIK 1846282) reported 14 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-03). Recent activity: Sell ORGO (14,687 shares), Buy ORGO (44,040 shares), Buy ORGO (195,312 shares), Buy ORGO (43,602 shares), Sell ORGO (14,541 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-03 | Organogenesis Holdings Inc. (ORGO) | Chief Financial Officer | Sell | 14,687 | $56,398 |
| 2026-03-03 | Organogenesis Holdings Inc. (ORGO) | Chief Financial Officer | Buy | 44,040 | $0 |
| 2026-02-20 | Organogenesis Holdings Inc. (ORGO) | Chief Financial Officer | Buy | 195,312 | $0 |
| 2026-02-20 | Organogenesis Holdings Inc. (ORGO) | Chief Financial Officer | Buy | 43,602 | $0 |
| 2026-02-20 | Organogenesis Holdings Inc. (ORGO) | Chief Financial Officer | Sell | 14,541 | $55,837 |
| 2026-02-18 | Organogenesis Holdings Inc. (ORGO) | Chief Financial Officer | Sell | 3,898 | $14,540 |
| 2026-02-18 | Organogenesis Holdings Inc. (ORGO) | Chief Financial Officer | Sell | 21,412 | $79,867 |
| 2026-02-18 | Organogenesis Holdings Inc. (ORGO) | Chief Financial Officer | Sell | 13,369 | $49,866 |
| 2026-02-18 | Organogenesis Holdings Inc. (ORGO) | Chief Financial Officer | Sell | 13,769 | $51,358 |
| 2025-02-21 | Organogenesis Holdings Inc. (ORGO) | Chief Financial Officer | Buy | 165,156 | $0 |
| 2025-02-19 | Organogenesis Holdings Inc. (ORGO) | Chief Financial Officer | Sell | 11,765 | $43,530 |
| 2025-02-19 | Organogenesis Holdings Inc. (ORGO) | Chief Financial Officer | Sell | 19,528 | $72,254 |
| 2025-02-19 | Organogenesis Holdings Inc. (ORGO) | Chief Financial Officer | Sell | 2,960 | $10,952 |
| 2025-02-19 | Organogenesis Holdings Inc. (ORGO) | Chief Financial Officer | Sell | 804 | $2,975 |
Source: SEC Form 4 filings · as of 2026-03-03